Discover Rinvoq’s transformative power in managing Ankylosing Spondylitis. Experience reduced pain, improved mobility, and enhanced quality of life.
What is Ankylosing Spondylitis?
Ankylosing spondylitis is a chronic inflammatory disease that primarily affects the spine, causing inflammation and pain in the joints and ligaments. It is a type of arthritis that can also affect other parts of the body, such as the eyes, skin, and heart. The inflammation caused by ankylosing spondylitis can lead to the fusion of the vertebrae in the spine, resulting in stiffness and pain. This condition predominantly affects individuals between the ages of 20 and 45, and it is more common in men than women.
The exact cause of ankylosing spondylitis is unknown, but genetic factors are believed to play a significant role. Certain genes, such as HLA-B27, have been associated with an increased risk of developing the condition. Additionally, environmental factors, such as infections or trauma, may also contribute to the development of ankylosing spondylitis.1
Symptoms of ankylosing spondylitis can vary from person to person and may include: back pain and stiffness, especially in the morning; pain and stiffness in other joints, such as the hips, shoulders, and knees; eye inflammation (uveitis); skin rashes; fatigue; and weight loss. The severity of symptoms can range from mild to severe, and the course of the disease can vary from person to person.
How Rinvoq Can Help
Rinvoq (upadacitinib) is a prescription medication used to treat adults with moderately to severely active ankylosing spondylitis. It belongs to a class of medications known as Janus kinase (JAK) inhibitors, which work by blocking the action of certain enzymes involved in the inflammatory process. By inhibiting these enzymes, Rinvoq helps to reduce inflammation and improve symptoms associated with ankylosing spondylitis.2
Rinvoq has been shown to be effective in reducing pain, stiffness, and inflammation in people with ankylosing spondylitis. In clinical trials, Rinvoq significantly improved symptoms and reduced the need for non-steroidal anti-inflammatory drugs (NSAIDs) and other pain relievers. Additionally, Rinvoq has been shown to improve physical function and quality of life in people with ankylosing spondylitis.
Rinvoq is typically taken orally once daily, with or without food. The dosage may vary depending on the individual’s response to the medication and the severity of their condition. It is important to follow the dosing instructions provided by a healthcare professional and to take Rinvoq exactly as prescribed.
Rinvoq: Benefits and Considerations
Rinvoq offers several benefits for people with ankylosing spondylitis, including:
- Effective in reducing pain, stiffness, and inflammation: Rinvoq has been shown to be effective in reducing pain, stiffness, and inflammation in people with ankylosing spondylitis.
- Improvement in physical function and quality of life: Rinvoq has been shown to improve physical function and quality of life in people with ankylosing spondylitis.
- Convenient once-daily dosing: Rinvoq is typically taken orally once daily, with or without food, making it convenient for people to manage their condition.
However, it is important to consider the potential risks and side effects associated with Rinvoq, including:
- Increased risk of infection: Rinvoq may increase the risk of developing infections, such as pneumonia and urinary tract infections.
- Gastrointestinal side effects: Rinvoq may cause gastrointestinal side effects, such as nausea, vomiting, and diarrhea.
- Potential for serious side effects: Rinvoq may cause serious side effects, such as blood clots, liver damage, and lymphoma. It is important to discuss the potential risks and benefits of Rinvoq with a healthcare professional before starting treatment.
Learn More About Ankylosing Spondylitis
For more information about ankylosing spondylitis and treatment options, including Rinvoq, individuals are encouraged to consult with a healthcare professional. They can provide personalized advice and guidance based on an individual’s specific needs and circumstances.